Moreover, since Ki-67 expression predicts the differential response of cell lines to CDK inhibitors treatment during xenograft tumour formation [24], understanding how Ki-67 expression and sensitivity to its depletion are linked is an important goal for developing stratified approaches to cancer therapies. The gene discussed is MKI67; the disease is neoplasm.